Yang Nianqin, Lu Jidong, Lu Yongning, Guo Jianming, Wang Hang
Melanoma Res. 2019 Feb;29(1):59-64. doi: 10.1097/CMR.0000000000000521.
The incidence of primary malignant melanoma (MM) of female urethra is extremely low, leading to paucity of recommendations on management. The objectives of our study were to gain more insight into the clinical features, diagnosis, treatment, and prognosis of this rare type of tumor. We carried out a retrospective analysis of all four cases who underwent an operation in our hospital since 1980. Moreover, other 32 cases of MM that have been reported in Chinese papers were also included for further review. The age of the patients ranged from 38 to 81 years. A mass in the urethral meatus and hematuria are common presentations. The final diagnosis depends on histopathological examination. After surgery alone or combined with chemotherapy/radiotherapy/immunotherapy, all cases were followed for 1-151 months, whereas only one lived for more than 4 years after receiving the diagnosis. A timely and accurate diagnosis of MM is critical, especially for hypomelanotic and amelanotic cases. Immunohistochemical staining and electron microscopy are necessary for a precise diagnosis in some cases. Extensive resection, early chemotherapy, and immunotherapy may help to improve survival.
女性尿道原发性恶性黑色素瘤(MM)的发病率极低,导致关于其治疗的建议很少。我们研究的目的是更深入地了解这种罕见肿瘤的临床特征、诊断、治疗和预后。我们对自1980年以来在我院接受手术的所有4例病例进行了回顾性分析。此外,还纳入了中文文献中报道的其他32例MM病例进行进一步复习。患者年龄在38至81岁之间。尿道口肿物和血尿是常见表现。最终诊断取决于组织病理学检查。单独手术或联合化疗/放疗/免疫治疗后,所有病例均随访1至151个月,而只有1例在确诊后存活超过4年。及时准确地诊断MM至关重要,尤其是对于无色素沉着和无黑色素沉着的病例。在某些情况下,免疫组织化学染色和电子显微镜检查对于精确诊断是必要的。广泛切除、早期化疗和免疫治疗可能有助于提高生存率。